Imran Vhora
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 9
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 9
- Co-authors
- Ambikanandan Misra (17 shared papers)Sushilkumar Patil (12 shared papers)Dipesh Baradia (7 shared papers)Chetan Yewale (2 shared papers)Girish Kore (1 shared paper)Priyanka Bhatt (8 shared papers)Rohan Lalani (7 shared papers)Jitendra Amrutiya (5 shared papers)
- Journals
- AAPS PharmSciTech (5 papers)Journal of Controlled Release (3 papers)RSC Advances (2 papers)Pharmaceutical Research (2 papers)Current Pharmaceutical Design (2 papers)
- Partner nations
- IndiaUnited StatesSaudi Arabia
In The Last Decade
Imran Vhora
25 papers receiving 1.8k citations
Imran Vhora's Hit Papers
Peers
Comparison fields: 5 of 112
- Biomaterials 592
- Pharmaceutical Science 222
- Molecular Medicine 63
- Molecular Biology 841
- Oncology 296
Countries citing papers authored by Imran Vhora
This map shows the geographic impact of Imran Vhora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imran Vhora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imran Vhora more than expected).
Fields of papers citing papers by Imran Vhora
This network shows the impact of papers produced by Imran Vhora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imran Vhora. The network helps show where Imran Vhora may publish in the future.
Co-authors
The 25 scholars most cited alongside Imran Vhora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PEG — A versatile conjugating ligand for drugs and drug delivery systems Hit paper breakdown → | 2014 | 554 |
| 2 | Epidermal growth factor receptor targeting in cancer: A review of trends and strategies Hit paper breakdown → | 2013 | 418 |
| 3 | 2017 | 130 | |
| 4 | 2015 | 79 | |
| 5 | 2013 | 73 | |
| 6 | 2014 | 52 | |
| 7 | 2019 | 52 | |
| 8 | 2014 | 48 | |
| 9 | 2016 | 43 | |
| 10 | 2014 | 43 | |
| 11 | 2014 | 40 | |
| 12 | 2016 | 31 | |
| 13 | 2017 | 31 | |
| 14 | 2017 | 29 | |
| 15 | 2020 | 29 | |
| 16 | 2018 | 28 | |
| 17 | 2018 | 27 | |
| 18 | 2018 | 25 | |
| 19 | 2015 | 23 | |
| 20 | 2018 | 21 |
About Imran Vhora
Imran Vhora is a scholar working on Molecular Biology, Biomaterials, Pharmaceutical Science, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (9 papers), Advanced biosensing and bioanalysis techniques (9 papers), Advanced Drug Delivery Systems (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Phytochemistry and Bioactivity Studies (1 paper). The work is most often cited by research in Biomaterials (592 citations), Pharmaceutical Science (222 citations), Molecular Medicine (63 citations), Molecular Biology (841 citations) and Oncology (296 citations). Imran Vhora has collaborated with scholars based in India, United States and Saudi Arabia. Frequent co-authors include Ambikanandan Misra, Sushilkumar Patil, Dipesh Baradia, Chetan Yewale, Girish Kore, Priyanka Bhatt, Rohan Lalani, Jitendra Amrutiya, Rajashree Mashru and Nusrat Chowdhury. Their work appears in journals such as AAPS PharmSciTech, Journal of Controlled Release, RSC Advances, Pharmaceutical Research and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.